COMP <GO>
QDEL vs NNNN // FORWARD P/E MULTIPLE
QuidelOrtho Corporation (NASDAQ) VS. Anbio Biotechnology (Class A) (NASDAQ) • 15-METRIC TALLY: QDEL 2
— NNNN 6
■ METRIC PARITY
LAST: $13.76 (-1.78%) • MKT CAP: $943.6M
forward-pe
—
LAST: $3.72 (-3.12%) • MKT CAP: $535.3M
forward-pe
77.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QDEL VS. NNNN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QDEL | NNNN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 87.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 17.00% | -52.00 | NNNN | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 91.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.80% | -1.26% | -7.54 | NNNN | /fcf-yield <GO> |
| Operating Margin | -33.70% | 66.70% | -100.40 | NNNN | /operating-margins <GO> |
| Net Profit Margin | -41.50% | 68.00% | -109.50 | NNNN | /net-margins <GO> |
| Revenue Growth (YoY) | -1.90% | 5.60% | -7.50 | NNNN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | NNNN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.1 | 29.4 | +21.64 | QDEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | 77.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $943.6M | $535.3M | $408.3M | QDEL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QDEL REV | NNNN REV | QDEL GROSS % | NNNN GROSS % | QDEL FCF | NNNN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $8.6M | — | 87.2% | -$83.0M | -$6.7M |
| FY 2024 | $2.78B | $8.2M | — | 71.9% | -$112.1M | $2.1M |
| FY 2023 | $3.00B | $6.7M | — | — | $280.2M | $898.4K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QDEL // BETA —
NNNN // BETA —